BioInvent Announces Extraordinary General Meeting

• BioInvent will hold an extraordinary general meeting at Alfahuset in Lund on December 1, 2026, to vote on a rights issue.
• Final issue terms are due by November 27; the proposed subscription period runs December 7-21, with a December 3 record date.
• Proposed amendments would raise share capital limits to SEK 18 million–72 million and share-count limits to 90,000,000–360,000,000.
• Shareholders will also vote on expanding the board to seven members through the election of Dharminder Chahal.
• Existing per-director fees would remain unchanged, with Chahal’s remuneration prorated for his service period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioInvent International AB published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.